Julie Krop

2019

In 2019, Julie Krop earned a total compensation of $1.3M as Chief Medical Officer and Executive Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$148,469
Option Awards$195,255
Salary$468,689
Stock Awards$446,850
Other$11,200
Total$1,320,463

Krop received $468.7K in salary, accounting for 35% of the total pay in 2019.

Krop also received $50K in bonus, $148.5K in non-equity incentive plan, $195.3K in option awards, $446.9K in stock awards and $11.2K in other compensation.

Rankings

In 2019, Julie Krop's compensation ranked 7,955th out of 13,971 executives tracked by ExecPay. In other words, Krop earned more than 43.1% of executives.

ClassificationRankingPercentile
All
7,955
out of 13,971
43rd
Division
Manufacturing
3,135
out of 5,701
45th
Major group
Chemicals And Allied Products
1,188
out of 2,200
46th
Industry group
Drugs
1,014
out of 1,886
46th
Industry
Pharmaceutical Preparations
754
out of 1,398
46th

Pay ratio

Julie Krop's Pay$1,320,463
Median Employee's Pay$189,221
Pay Ratio

7

to 1

In 2019, the annual total compensation of Julie Krop was $1,320,463.

The annual total compensation of the median employee at AMAG Pharmaceuticals was $189,221.

The ratio of Julie Krop's pay to the pay of median employee was therefore 7 to one.

Source: SEC filing on April 29, 2020.

Krop's colleagues

We found four more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2019.

2019

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2019

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2019

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

2019

Anthony Casciano

AMAG Pharmaceuticals

Chief Commercial Officer

News

You may also like